Ayala Pharmaceuticals
Latest round
- Series B
Last raised
- May 2019
Total raised
- $47M
Investors
- 5
About Ayala Pharmaceuticals
Ayala Pharmaceuticals, Inc.Founded in 2017, Ayala Pharmaceuticals, Inc. is based in Wilmington, US, and specializes in the development of cancer therapies. The company has undergone strategic adaptations, including its recent merger with Advaxis, Inc. in October 2022 and a planned merger with BioSight Ltd. in late Q3 2023.Ayala Pharmaceuticals, Inc. specializes in developing innovative therapies aimed at treating various forms of cancer, focusing on products such as AL102 and AL101. These therapies target specific pathways involved in tumor growth, selectively inhibiting tumor cell proliferation while minimizing effects on healthy cells.In the most recent year of 2022, Ayala Pharmaceuticals reported a revenue of USD 692,000 with an EBITDA of USD -37,341,000., the company aims to enhance its product portfolio and expand its market reach. The recent merger with Advaxis, Inc. has positioned Ayala for broader market opportunities, and the company is focused on launching new products in the oncology sector. Specific expansion into new markets, particularly in North America, Europe, and Asia, will be targeted as part of their growth strategy.
Who invested in Ayala Pharmaceuticals
5 investors across 2 rounds
See all investors in Ayala Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ayala Pharmaceuticals
Who invested in Ayala Pharmaceuticals?
Ayala Pharmaceuticals has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ayala Pharmaceuticals raised?
Ayala Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ayala Pharmaceuticals last raise money?
Ayala Pharmaceuticals's most recent round on record is a Series B, in May 2019.
What does Ayala Pharmaceuticals do?
Ayala Pharmaceuticals is a biotechnology company.
Where is Ayala Pharmaceuticals headquartered?
Ayala Pharmaceuticals is headquartered in Wilmington, US.
Which VCs invest in companies like Ayala Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ayala Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ayala Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.